Before the law, there was no cap on what Medicare enrollees might have to spend on medications covered by their Part D drug plans.

A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual out-of-pocket spending on prescription drugs to $2,000 for Medicare beneficiaries.

Billionaire entrepreneur Mark Cuban has been vocal about reshaping the U.S. health care system for years. During recent appearances on podcasts Fishbowl with Jules Terpak and Ground Truths with Dr.

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

Medicare recipients will see a $2,000 out-of-pocket cap on some prescription drugs as part of several new provisions coming in 2025.

Ozempic's meteoric rise has reshaped the landscape of healthcare, retail, and consumer behavior. Its initial popularity as a weight loss ...

Mark Cuban Cost Plus Drug Co. has seen exponential growth since its launch, supplying thousands of healthcare facilities with discounted generics in shortage.

The bipartisan agreement will fund the government through March. It could also reshape the pharmacy supply chain by reforming ...

Plus, a Philly judge has ordered a retrial of the $45 million malpractice verdict against Temple, and a Bucks County doctor ...

Bipartisan bills in Congress would rein them in. And businesses such as Mark Cuban’s Cost Plus Drugs and smaller, “transparent PBMs” have tried to wean pharmaceutical companies and health plans from ...